PReS13-SPK-1579: Biologic agents for the treatment of rheumatic diseases

被引：0
|
作者：
P Emery
机构：
[1] University of Leeds,
来源：
Pediatric Rheumatology | / 11卷 / Suppl 2期
关键词：
Public Health; Rheumatoid Arthritis; Arthritis; Methotrexate; Rheumatic Disease;
D O I：
10.1186/1546-0096-11-S2-I27
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2011
    Furst, D. E.
    Keystone, E. C.
    Braun, J.
    Breedveld, F. C.
    Burmester, G. R.
    De Benedetti, F.
    Doerner, T.
    Emery, P.
    Fleischmann, R.
    Gibofsky, A.
    Kalden, J. R.
    Kavanaugh, A.
    Kirkham, B.
    Mease, P.
    Sieper, J.
    Singer, N. G.
    Smolen, J. S.
    Van Riel, P. L. C. M.
    Weisman, M. H.
    Winthrop, K.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 : 2 - 45
  • [42] Impact of Biological Agents and Tissue Engineering Approaches on the Treatment of Rheumatic Diseases
    da Silva, Marta Alves
    Martins, Albino
    Teixeira, Ana A.
    Reis, Rui L.
    Neves, Nuno M.
    [J]. TISSUE ENGINEERING PART B-REVIEWS, 2010, 16 (03) : 331 - 339
  • [43] Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2012
    Furst, Daniel E.
    Keystone, Edward Clark
    So, Alexander K.
    Braun, Juergen
    Breedveld, Ferry C.
    Burmester, Gerd R.
    De Benedetti, Fabrizio
    Doerner, Thomas
    Emery, Paul
    Fleischmann, Roy
    Gibofsky, Allan
    Kalden, J. R.
    Kavanaugh, Arthur
    Kirkham, Bruce
    Mease, Philip
    Rubbert-Roth, A.
    Sieper, Joachim
    Singer, Nora G.
    Smolen, Josef S.
    Van Riel, Piet L. C. M.
    Weisman, Michael H.
    Winthrop, Kevin L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 2 - 34
  • [44] Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2008
    Furst, D. E.
    Keystone, E. C.
    Kirkham, B.
    Fleischmann, R.
    Mease, P.
    Breedveld, F. C.
    Smolen, J. S.
    Kalden, J. R.
    Burmester, G. R.
    Braun, J.
    Emery, P.
    Winthrop, K.
    Bresnihan, B.
    De Benedetti, F.
    Doerner, T.
    Gibofsky, A.
    Schiff, M. H.
    Sieper, J.
    Singer, N.
    Van Riel, P. L. C. M.
    Weinblatt, M. E.
    Weisman, M. H.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 : 2 - 25
  • [45] Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
    Furst, D. E.
    Keystone, E. C.
    Braun, J.
    Breedveld, F. C.
    Burmester, G. R.
    De Benedetti, F.
    Doerner, T.
    Emery, P.
    Fleischmann, R.
    Gibofsky, A.
    Kalden, J. R.
    Kavanaugh, A.
    Kirkham, B.
    Mease, P.
    Sieper, J.
    Singer, N. G.
    Smolen, J. S.
    Van Riel, P. L. C. M.
    Weisman, M. H.
    Winthrop, K.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 : I2 - I36
  • [46] A medicoeconomic review of early intervention with biologic agents in the treatment of inflammatory bowel diseases
    Odes, Shmuel
    Greenberg, Dan
    [J]. CLINICOECONOMICS AND OUTCOMES RESEARCH, 2014, 6 : 431 - 443
  • [47] Is It Possible to Predict Which Patients Treated with Biologic Agents for Rheumatic Diseases Will Develop Anti-Drug Antibodies ?
    Zufferey, Pascal
    Jeanfavre, Melanie Favre Dit
    Dumusc, Alexandre
    Benaim, Charles
    Perreau, Matthieu
    So, Alexander K., Sr.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [48] It is possible to predict which patients treated with biologic agents for rheumatic diseases will develop anti-drug antibodies?
    Melanie, Favre Dit Jeanfavre
    Charles, Benaim
    Alexander, So
    Mathieu, Perreau
    Pascal, Zufferey
    [J]. SWISS MEDICAL WEEKLY, 2016, 146 : 7S - 7S
  • [49] Our Strategy of Preventing Tuberculosis (TB) in Patients with Rheumatic Diseases Under the Treatment with Biologic Dmards
    Motojima, Shinji
    Nakashita, Tamao
    Jibatake, Akira
    Yoshida, Akira
    Yamamoto, Yoshiki
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [50] PReS-FINAL-1015: A systematic literature review on diagnosis and treatment of pediatric rheumatic diseases: a shared initiative
    V Boom
    N de Graeff
    F Belutti Enders
    N Groot
    N ter Haar
    F Sperotto
    S Vastert
    N Wulffraat
    [J]. Pediatric Rheumatology, 11 (Suppl 2)
12345